n-3 Omega fatty acids: a review of current knowledge

被引:238
作者
Gogus, Ugur [1 ]
Smith, Chris [2 ]
机构
[1] Middle E Tech Univ, Vocat Sch Higher Educ, Food Technol Program, TR-06531 Ankara, Turkey
[2] Univ Chester, Dept Biol Sci, Chester CH1 4BJ, Cheshire, England
关键词
Food; n-3 omega fatty acids; nutrition; public health and disease; polyunsaturated fatty acid; FISH-OIL SUPPLEMENTATION; MAJOR DEPRESSIVE DISORDER; PLACEBO-CONTROLLED TRIAL; LOW-DENSITY LIPOPROTEINS; BLOOD-CELL MEMBRANES; DOUBLE-BLIND; DIETARY-FAT; EICOSAPENTAENOIC ACID; DOCOSAHEXAENOIC ACID; CARDIOVASCULAR-DISEASE;
D O I
10.1111/j.1365-2621.2009.02151.x
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
P>The very long chain polyunsaturated fatty acids (PUFAs) (C18-C22) and n-3 Omega PUFAs are apparently widely accepted as a part of modern nutrition because of their beneficial effects on metabolism. Most significantly, the reported protective effect of the n-3 omega fatty acids in relation to cardiovascular inflammatory diseases and cancer has led people to consider these fatty acids more beneficial than other dietary supplements. Unfortunately, there is a lack of studies relating to the physical performance increasing effect in sports diets, cholesterol-reducing effect in meat technology, effects on human serum profile, the application dose and the side effects with/without omega-6 PUFAs, which has left us with several crucial unanswered questions. We still do not know the correct dose of n-3 omega and the correct ratio of n-3 omega to n-6 omega or their possible contraindications when combined with drugs, other foods and herbal supplements. Another reported aspect of n-3 omega PUFAs is that they protect and even enhance the effect in medical treatment of important diseases such as Alzheimer's, multiple sclerosis and cancer. These reports led to PUFAs becoming one of the most accepted and consumed food supplements. Despite this weight of evidence and the considerable current use, there is still a need for studies, which will determine whether the n-3 omega fatty acids are in fact important functional supplements with no adverse effects. This review will attempt to outline the current position of n-3 omega fatty acids in the field of clinical nutrition and healthcare and outline the studies needed to determine whether there are significant advantages in taking them as food supplement without any adverse effects.
引用
收藏
页码:417 / 436
页数:20
相关论文
共 194 条
[1]   Mechanisms of disease:: Sodium and potassium in the pathogenesis of hypertension [J].
Adrogue, Horacio J. ;
Madias, Nicolaos E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (19) :1966-1978
[2]   Omega-3 fatty acid status in attention-deficit/hyperactivity disorder [J].
Antalis, Caryl J. ;
Stevens, Laura J. ;
Campbell, Mary ;
Pazdro, Robert ;
Ericson, Karen ;
Burgess, John R. .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2006, 75 (4-5) :299-308
[3]  
ARKHIPENKO YV, 1995, PATHOPHYSIOLOGY, V2, P131
[4]   EICOSAPENTAENOIC ACID (EPA) PRODUCTION FROM MICROORGANISMS - A REVIEW [J].
BAJPAI, P ;
BAJPAI, PK .
JOURNAL OF BIOTECHNOLOGY, 1993, 30 (02) :161-183
[5]  
BAKER DG, 2005, ARTHRITIS RHEUMATISM, V32, P1273
[6]   PLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS [J].
BANG, HO ;
DYERBERG, J ;
NIELSON, AB .
LANCET, 1971, 1 (7710) :1143-&
[7]   Dietary fish oil - Influence on lesion regression in the porcine model of atherosclerosis [J].
Barbeau, ML ;
Klemp, KF ;
Guyton, JR ;
Rogers, KA .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (04) :688-694
[8]   The effect of an oral nutritional supplement enriched with fish oil on weight loss in patients with pancreatic cancer [J].
Barber, MD ;
Ross, JA ;
Voss, AC ;
Tisdale, MJ ;
Fearon, KCH .
BRITISH JOURNAL OF CANCER, 1999, 81 (01) :80-86
[9]   DIETARY FISH-OIL INHIBITS HUMAN ERYTHROCYTE MG,NAK-ATPASE [J].
BARTOLI, GM ;
PALOZZA, P ;
LUBERTO, C ;
FRANCESCHELLI, P ;
PICCIONI, E .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 213 (03) :881-887
[10]   A DOUBLE-BLIND CONTROLLED TRIAL OF LONG-CHAIN N-3 POLY-UNSATURATED FATTY-ACIDS IN THE TREATMENT OF MULTIPLE-SCLEROSIS [J].
BATES, D ;
CARTLIDGE, NEF ;
FRENCH, JM ;
JACKSON, MJ ;
NIGHTINGALE, S ;
SHAW, DA ;
SMITH, S ;
WOO, E ;
HAWKINS, SA ;
MILLAR, JHD ;
BELIN, J ;
CONROY, DM ;
GILL, SK ;
SIDEY, M ;
SMITH, AD ;
THOMPSON, RHS ;
ZILKHA, K ;
GALE, M ;
SINCLAIR, HM .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (01) :18-22